Enova International, Inc. filed a Form 8-K on November 6, 2026, disclosing that its wholly-owned indirect subsidiary OnDeck Asset Securitization IV, LLC intends to offer $500,251,000 in fixed-rate asset-backed notes in a private securitization transaction announced on November 3, 2026.
Fox Corporation filed a current report on Form 8-K on November 6, 2026, disclosing the completion of its acquisition of Roku, Inc. and reporting entry into three new credit agreements totaling more than $10.4 billion in borrowing capacity.
HF Foods Group Inc. filed an 8-K/A (Amendment No. 1) on November 6, 2026, amending and supplementing two earlier current reports related to its acquisition of Searay Foods Inc. and Morgan Foods Inc., and correcting a previously reported revenue growth figure for the acquired …
DTE Energy Company filed a Form 8-K on November 6, 2026, under Regulation FD, disclosing that it will meet with investors on November 8-10, 2026, and furnishing a slide presentation as Exhibit 99.1.
Cantor Fitzgerald Income Trust, Inc. filed a Form 8-K on November 6, 2026, disclosing that its board of directors declared October 2026 distributions across all classes of common stock and operating partnership units, with payment on or about November 6, 2026.
GeoVax Labs, Inc. filed an 8-K on November 6, 2026, disclosing that its Board of Directors terminated President and Chief Executive Officer David A. Dodd for Cause, effective November 5, 2026.
Fractyl Health, Inc. filed a Form 8-K on November 6, 2026, disclosing the appointment of Michael Wartell as an independent Class III director effective November 2, 2026, along with the terms of his compensation agreement.
Jaguar Health, Inc. filed an 8-K on November 6, 2026, disclosing the voting results from a special meeting of stockholders held that same day, at which all six submitted proposals were approved.
D. Boral Acquisition I Corp. filed a Form 8-K on November 6, 2026, disclosing the September 23, 2026 resignation of director Benjamin Piggott and subsequent board committee appointments.
Curis, Inc. filed a Form 8-K on November 6, 2026, disclosing that it received a Delist Determination Letter from Nasdaq on November 2, 2026, citing the company's failure to maintain the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq …